Type II c-Met inhibitors: molecular insight into crucial interactions for effective inhibition
Authors:
- 11 July 2021
- journal article
- research article
- Published by Springer Nature in Molecular Diversity
- Vol. 26 (3) , 1411-1423
Abstract
The c-Met tyrosine kinase plays an important role in human cancers. Preclinical studies demonstrated that c-Met is over-expressed, mutated and amplified in a variety of human tumor types and design of more potent c-Met inhibitors is a priority. In this study, 14 molecular dynamics simulations of potent type II c-Met inhibitors were run to resolve the critical interactions responsible for high affinity of ligands towards c-Met considering the essential flexibility of protein–ligand interactions. Residues Phe1223 and Tyr1159, involved in pi-pi interactions were recognized as the most effective residues in the ligand binding in terms of binding free energies. Hydrogen bond interaction with Met1160 was also found necessary for effective type II ligand binding to c-Met. Graphic abstractKeywords
Funding Information
- Vice-Chancellor for Research, Shiraz University of Medical Sciences (98-01-12-20089)
This publication has 33 references indexed in Scilit:
- Lessons from (S)-6-(1-(6-(1-Methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)ethyl)quinoline (PF-04254644), an Inhibitor of Receptor Tyrosine Kinase c-Met with High Protein Kinase Selectivity but Broad Phosphodiesterase Family Inhibition Leading to Myocardial Degeneration in RatsJournal of Medicinal Chemistry, 2013
- Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agentProceedings of the National Academy of Sciences, 2013
- GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkitBioinformatics, 2013
- LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft modelsInvestigational New Drugs, 2012
- ACPYPE - AnteChamber PYthon Parser interfacEBMC Research Notes, 2012
- Structure-Based Design of Novel Class II c-Met Inhibitors: 1. Identification of Pyrazolone-Based DerivativesJournal of Medicinal Chemistry, 2012
- Investigation of Atomic Level Patterns in Protein—Small Ligand InteractionsPLOS ONE, 2009
- Hydrophobic, Hydrophilic, and Charged Amino Acid Networks within ProteinBiophysical Journal, 2007
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Electrostatics of nanosystems: Application to microtubules and the ribosomeProceedings of the National Academy of Sciences, 2001